Bioventix PLC Registered Shares LS -,05

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

41.55%

Market Cap

-

P/E Ratio

18.93

Dividend Yield

5.45 %

Earnings per Share

1.73 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE17.5 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 12:51:07 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW17.517.2
PREV. DAY'S PRICE17.3 (07/20)
CHANGE DAY BEFORE
+0.20
1.16 %
52 WEEK HIGH / LOW31.6 (07/23)16.1 (03/03)

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
1.851.811.73--
DIVIDENDS PER SHARE
1.751.801.79--
DIVIDEND YIELD IN %
3.95 %3.52 %5.45 %--
DIVIDEND GROWTH IN %
-2.60 %3.12 %-1.05 %--
PRICE - EARNINGS RATIO
23.9728.3718.93--
PRICE - BOOK RATIO
16.6619.1312.44--
PRICE - SALES RATIO
15.8917.1311.10--
PRICE - CASH FLOW RATIO
25.7727.2720.15--
Further Key Figures

Master Data

WKN
A113DD
ISIN
GB00B4QVDF07
SYMBOL
51B
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
BIOVENTIX PLC LS -,05
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.89 %
-9.90 %
-12.63 %
-15.20 %
-41.55 %
-59.20 %
-59.58 %
-12.63 %
HIGH18.7020.4020.6021.4031.6057.0057.0022.20
LOW17.1017.1017.1016.1016.1016.1016.1016.10

Dividende

pro Aktie

Company profile

Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.